Approval · Notice of Compliance 22289 · 2019
POSANOL: Notice of Compliance 22289
Issued June 14, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22289
- Date
- June 14, 2019
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Expanded set of admixture diluents, and removal of in-line filter and corresponding changes to label.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| POSANOL | Not yet assigned | — |
Medicinal ingredients
- POSACONAZOLE 18 MG per ML